September 12, 2021
NervGen Pharma
Coverage Universe
NervGen is not an investment for the faint of heart, but for those investors who like to bet on trailblazing biotech companies with truly novel, disease modifying, science, and moonshot […]
September 6, 2021
Sept 6, 2021
Coverage Updates
We generally don’t focus on the macro when writing our updates, but unfortunately, we can’t dive into company-specific updates without spending a minute on the poor market sentiment around biotech, […]